uploads/2017/12/STOCK-PRICE-1.png

BD’s Stock Price Performance after Recent 52-Week High

By

Updated

BD’s stock performance

On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock’s 50-day moving average stands at $221.22 while the stock’s 200-day moving average is $205.17. So the company is currently trading below its 50-day moving average but higher than its 200-day moving average.

On November 2, BD announced its 4Q17 and full fiscal 2017 earnings. The results surpassed analysts’ estimates and registered solid performance over the period. The company expects its strong earnings performance to continue over the next fiscal year. For more, read Why BD’s Earnings Growth Is Expected to Continue. On the earnings announcement day, the stock price registered a record high as of November 2. As of December 29, BD registered a 52-week high of $229.69 on December 1. On January 1, BD was trading at its 52-week low at a share price of $161.5.

YTD (year-to-date), BD stock has witnessed a rise of ~29.5%. Over the last six months, the stock has registered growth of approximately 10%. However, over the past month, BD stock has declined approximately 5.7%.

Peer and industry comparison

Over the past year, BD has registered a stock price return of ~28.7%. The return registered by S&P 500 Index during the same period stands at ~18.7%. The US medical device sector (IHI) has registered gains of ~31% over the last 12 months, which shows that BD stock has overperformed the broader market but marginally underperformed the US medical device industry.

On December 28, BD’s peers Thermo Fiser Scientific (TMO), Stryker (SYK), and Zimmer Biomet Holdings (ZBH) registered 12-month returns of approximately 34.7%, 28.9%, and 19%, respectively.

More From Market Realist